Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SES Research is a Houston-based company specializing in the manufacturing and supply of high-purity fullerenes and carbon nanomaterials. Founded in 1991, the company is a pioneer in the commercialization of Carbon 60 (C60), a molecule known for its unique physical and chemical properties. While serving industrial and electronics sectors, SES Research has a significant presence in the life sciences through its production of C60 for longevity and antioxidant research. The company provides C60 in various grades, including ESS60, which is specifically processed for research into health and longevity applications. Their manufacturing process utilizes the carbon arc method followed by rigorous purification via high-performance liquid chromatography (HPLC). SES Research continues to be a primary source of materials for academic and private researchers exploring the biomedical applications of carbon nanostructures.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SES Research.